glycine and vancomycinic acid. From elementary analyses and mass spectroscopic measurements, the molecular formulae of chloropolysporins A, B and C appear to be C89H09O39N8Cl3 (MW 2,008), C83H89O34N8Cl3 (MW 1, 846) and C77H7903oN8Cl3 (MW 1,700), respectively.
Their physico-chemical characterizations including molecular formulae revealed that chloropolysporins A, B and C were new membersof glycopeptide antibiotics.
As described in the preceding paper1}, chloropolysporins A, B and C, novel glycopeptide antibiotics, are produced by a new species of actinomycete designated as Faenia interjecta sp. nov. SANK 60983. In this paper, wereport fermentation, isolation, physico-chemical properties and degradation studies of chloropolysporins A, B and C.
Fermentation
One loopful growth of strain SANK60983 was inoculated into a 500-ml Erlenmeyer flask containing 80 ml of a medium composed of glucose 5.0%, pork meat powder 1.0%, NaCl 0.25 %, CaCO3 0.5% and Nissan Disfoam CB442 0.02%. The pH of the mediumwas adjusted to 7.2 before sterilization. The flask was cultivated on a rotary shaker at 28°C for 72 hours. A 25-ml aliquot of the culture from the Erlenmeyer flask was inoculated into six 2-liter Erlenmeyer flasks each containing 500 ml of the mediumdescribed above and cultivated on a rotary shaker at 28°C for 24 hours. A 3-liter aliquot of the culture was transferred into an 100-liter fermentor containing 60 liters of the same mediumand this seed cultivation was conducted at 28°C for 24 hours. After inoculation of 15 liters of the culture into a 600-liter fermentor containing 300 liters of the medium described above, fermentation was carried out for 96 hours under agitation of 125 rpm, aeration of 300 liters per minute and inner pressure of 1.0 kg/cm2. Mycelial growth was expressed as a packed cell volume (ml) after centrifugation of 10 g of the culture broth at 3,000 rpm for 15 minutes. The maximal potency of chloropolysporins, 1,750 jug/ ml, was obtained after 96 hours of fermentation. Antibiotic production during fermentation was monitored by the HPLCmethod described later. A typical time course of the fermentation in the 600-liter fermentor is shown in Fig. 1 . The HPLCpattern of chloropolysporin complex, which were designated as chloropolysporins A, B, C, D and E in the order of their elution, is shown in Fig. 2 .
Two hundred g of 1 was dissolved in deionized water (10 liters), adjusted to pH 5.8 with 1 n NaOH and re-chromatographed on a Polyamide column (8.3 liters) by developing with deionized water to resolve two fractions. The first fraction (1.4 liters) and the second fraction (1.4 liters) contained chloro- polysporins A and B, respectively. Each of them was adjusted to pH 4.0 with 1 n HC1, concentrated in vacuo and lyophilized to yield 26 g of crude powder containing chloropolysporin A (2: Yield 90%, purity of chloropolysporin A 27%, chloropolysporin B 45 %) and 84 g of partially purified powder containing chloropolysporin B (3: Yield 72%, purity 83 %).
Main component, chloropolysporin B, was further purified from 3 (2 g) by HPLCon a preparative reverse phase column (Yamamura Co., Japan, YMC-Pack S-343 115 ODS, 20 x250 mm) developed with 16%aqueous acetonitrile solution containing 0.2% trifluoroacetic acid. The collected fractions containing chloropolysporin B were adjusted to pH 7.0 with 1 n NaOH,evaporated to remove acetonitrile and charged on a Diaion HP-20 column (100 ml) to change its salt form from trifluoroacetic acid salt to hydrochloride. For this purpose, the column was washed with distilled water (200 ml), subsequently with 0.1 n HC1 (200 ml) and again with distilled water (200 ml) and eluted with 50% aqueous acetone. Finally, the eluate was concentrated in vacuo to 4 ml, adjusted to pH 4.0 with 1 n HC1and lyophilized to yield 1.2 g of purified chloropolysporin B hydrochloride (yield 72%).
Twominor components, chloropolysporins A and C were purified as follows: For purification of chloropolysporin A, 320 mg of 2 dissolved in 50% aqueous methanol (6 ml) was applied to a TSK gel Toyopearl HW40-Fcolumn (Toyo Soda Co., Japan, 400 ml) equilibrated with the same solvent mixture. Although separation between chloropolysporins A and B was still not complete, the fractions containing chloropolysporins A and B in 1 : 1 ratio were combined, concentrated in vacuo and lyophilized to afford brownish powder (53 mg, yield 30%, purity 48%). A final purification was done by the same procedure as in the final purification step of chloropolysporin B except for a concentration of acetonitrile (10%). The pure fractions showing a single peak in the HPLCsystem were collected, desalted on a Diaion HP-20 column and lyophilized to yield 20 mg of chloropolysporin A hydrochloride (yield78%).
For purifying chloropolysporin C, 6 g of 1 dissolved in 1 liter of buffer solution of 0.01 m sodium heptane sulfonate containing 2.5 %acetic acid and 0.5 % concentrate NH4OH was pumpedon a Prep Pak-500 C18 column of Waters Prep LC/System (Waters Co., U.S.A.). Elution from this column was achieved with the same buffer solution except for addition of 16%acetonitrile2). The chloropolysporin C rich fractions were collected, evaporated to remove acetonitrile, adjusted to pH 7.0 with 6 n NaOHand desalted on a Diaion HP-20 column (100 ml). After washing with deionized water (200 ml), the antibiotic was eluted with 50 % aqueous acetone (200 ml), concentrated and lyophilized to obtain 840 mg of powder (yield 70%, purity 53 %). Further purification was done on a Lobar column RP-18 size B (Merck Co., West Germany) using the same solvent system. The fractions containing chloropolysporin C were combined, concentrated in vacuo, desalted on a Diaion HP-20 column and lyophilized to afford 500 mgof white powder (yield 70%, purity 62%). In order to remove chloropolysporin D, the lyophilized powder was applied to a Toyopearl HW40-Fcolumn (400 ml) and developed with 50% aqueous methanol. The pure fractions were combined, evaporated to removemethanol in vacuo and lyophilized to yield 247 mg of chloropolysporin C heptane sulfonate (yield 80%). The purification procedure described above was summarized in Fig. 3 . To elucidate primary physico-chemical properties of these pure materials, they were changed to sulfate salts by the method reported by McGahren et al.2\ Twominor components, chloropolysporins D and E, were determined to be the artificial epimers of B and C, respectively^.
Physico-chemical Properties
The sulfates of chloropolysporins A, B and C are all amphoteric, off-white powder, soluble in water and dimethyl sulfoxide, but insoluble in lower alcohols, acetone, ethyl acetate and ethyl ether. These antibiotics showed positive reactions for ferric chloride, iodine, Rydon-Smith reagent, ninhydrin and sulfuric acid on silica gel TLCplate. The molecular formulae of chloropolysporins A, B and C were established to be C89H99O39N8C13 (MW 2,008), C83H89O34N8C13 (MW 1,846) and C77H7903oN8Cl3
(MW1,700), respectively, by elementary analyses as well as their quasi molecular ion (M+H)+ by fast atom bombardment mass spectra (FAB-MS)in agreement with those of calculated nominal values. The UVspectra of these three compoundsshowed a characteristic absorption of glycopeptide antibiotics at 280 nm and their IR spectra indicated the presence of hydroxyl groups at 3400 cm" 1 and amide bonds between 1560 cm"1 to 1650 cm"1. These results as well as other physico-chemical properties of these compoundsare summarized in Tables 1, 2 
Degradation Studies
XHNMRand mass spectral analyses of the amino acid constituents obtained from the acid hydrolysate of all these three compounds (concentrate HC1 -CH3COOH,1 : 1, at 105°C 20 hours and/or HI/P, at 105°C, 20 hours0) indicated the presence of actinoidic acid, 3-chloro-4-hydroxyphenylglycine, TV-methyl-p-hydroxyphenylglycine and dideoxyvancomycinic acid (Fig. 7) . These unusual amino acids are typical constituents in glycopeptide antibiotics5).
The presence of 1 mol of glucose, mannose, rhamnose and galactose in chloropolysporin A, glucose, mannose and rhamnose in chloropolysporin B and glucose and mannose in chloropolysporin C were detected by gas chromatographic analysis of their hydrolysate (5% HC1in absolute MeOH, 105°C, 16 hours) followed by their trimethylsilylation.
Ristosamine was detected from each hydrolysate of chloropolysporins A, B and C (5% HC1 in absolute MeOH, 105°C, 5 hours). Further details of the degradation studies will be described in the subsequent paper on their structure elucidations50.
Comparative Studies Morethan fifteen groups of glycopeptide antibiotics have been reported as shownin Table 4 . The variety of their structures was mainly observed by their constituents of amino acids or amino sugars. In the point of the composition of amino acids, it was revealed that chloropolysporins were closely related to /3-avoparcin2'6), but chloropolysporins were clearly differed from /3-avoparcin in the existence of vancomycinic acid moiety in the former and monodechlorovancomycinic acid in the latter (Fig. 7) . Therefore, chloropolysporins A, B and C were demonstrated as new antibiotics.
